These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Control of NKT cell differentiation by tissue-specific microenvironments. Yang Y; Ueno A; Bao M; Wang Z; Im JS; Porcelli S; Yoon JW J Immunol; 2003 Dec; 171(11):5913-20. PubMed ID: 14634102 [TBL] [Abstract][Full Text] [Related]
7. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen. Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017 [TBL] [Abstract][Full Text] [Related]
8. CXCR6 deficiency ameliorates ischemia-reperfusion injury by reducing the recruitment and cytokine production of hepatic NKT cells in a mouse model of non-alcoholic fatty liver disease. Zhu H; Zhang Q; Chen G Int Immunopharmacol; 2019 Jul; 72():224-234. PubMed ID: 31002999 [TBL] [Abstract][Full Text] [Related]
9. CD1d-specific NK1.1+ T cells with a transgenic variant TCR. Sköld M; Faizunnessa NN; Wang CR; Cardell S J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049 [TBL] [Abstract][Full Text] [Related]
10. Natural killer T-cell populations in C57BL/6 and NK1.1 congenic BALB.NK mice-a novel thymic subset defined in BALB.NK mice. Stenström M; Sköld M; Andersson A; Cardell SL Immunology; 2005 Mar; 114(3):336-45. PubMed ID: 15720435 [TBL] [Abstract][Full Text] [Related]
11. Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets. Johnston B; Kim CH; Soler D; Emoto M; Butcher EC J Immunol; 2003 Sep; 171(6):2960-9. PubMed ID: 12960320 [TBL] [Abstract][Full Text] [Related]
12. Long-term retention of mature NK1.1+ NKT cells in the thymus. Berzins SP; McNab FW; Jones CM; Smyth MJ; Godfrey DI J Immunol; 2006 Apr; 176(7):4059-65. PubMed ID: 16547241 [TBL] [Abstract][Full Text] [Related]
13. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice. Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262 [TBL] [Abstract][Full Text] [Related]
14. Expression of CXCR6 on CD8(+) T cells was up-regulated in allograft rejection. Jiang X; Sun W; Zhu L; Guo D; Jiang H; Ma D; Jin J; Zhao Y; Liang J Transpl Immunol; 2010 Feb; 22(3-4):179-83. PubMed ID: 20035869 [TBL] [Abstract][Full Text] [Related]
15. Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance. Jiang X; Shimaoka T; Kojo S; Harada M; Watarai H; Wakao H; Ohkohchi N; Yonehara S; Taniguchi M; Seino K J Immunol; 2005 Aug; 175(4):2051-5. PubMed ID: 16081769 [TBL] [Abstract][Full Text] [Related]
16. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production. Ikarashi Y; Mikami R; Bendelac A; Terme M; Chaput N; Terada M; Tursz T; Angevin E; Lemonnier FA; Wakasugi H; Zitvogel L J Exp Med; 2001 Oct; 194(8):1179-86. PubMed ID: 11602646 [TBL] [Abstract][Full Text] [Related]
17. DOCK2 is required in T cell precursors for development of Valpha14 NK T cells. Kunisaki Y; Tanaka Y; Sanui T; Inayoshi A; Noda M; Nakayama T; Harada M; Taniguchi M; Sasazuki T; Fukui Y J Immunol; 2006 Apr; 176(8):4640-5. PubMed ID: 16585555 [TBL] [Abstract][Full Text] [Related]